Great West Life Assurance CO Rigel Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$1.1 - $12.2 $77,399 - $858,428	70,363 Added 793.54%	79,230 $93,000
Q2 2022 Aug 12, 2022	BUY	$0.67 - $3.19 $5,940 - $28,285	8,867 New	8,867 $10,000
Q2 2022 Aug 09, 2022	SELL	$0.67 - $3.19 $5,940 - $28,285	-8,867 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.78 - $4.13 $15,783 - $36,620	8,867 New	8,867 $21,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $15,783 - $36,620	-8,867 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$1.6 - $2.43 $14,187 - $21,546	8,867 New	8,867 $18,000
Q3 2019 Oct 25, 2019	SELL	$1.63 - $2.62 $27,240 - $43,785	-16,712 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.23 - $4.3 $53,979 - $71,861	16,712	16,712 $65,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.